• Publications
  • Influence
Many macroeconomists and policymakers have debated the effectiveness of the quantitative monetary-easing policy (QMEP) that was introduced in Japan in 2001. This paper measures the effect of the QMEPExpand
  • 55
  • 10
  • PDF
Financial and Capital Markets' Responses to Changes in the Central Bank's Target Interest Rate: The Case of Japan
We propose new proxy variables for monetary policy shocks in Japan for the period from July 1989 to March 2001 and investigate the effects of changes in the policy target variable on stock prices andExpand
  • 22
  • 3
FMRFamide-related peptides isolated from the prosobranch mollusc Fusinus ferrugineus.
In addition to FMRFamide and FLRFamide, four FMRFamide-related peptides were isolated from the ganglia of a prosobranch mollusc, Fusinus ferrugineus. Their primary structures were ALTNDHELRFamide,Expand
  • 29
  • 2
A molluscan neuropeptide related to the crustacean hormone, RPCH.
A peptide that potentiates twitch contraction of the radula retractor muscle of the prosobranch mollusc Fusinus ferrugineus was isolated from the ganglia of the animal. Its primary structure isExpand
  • 65
  • 1
The Sense of Agency in Driving Automation
Driving automation has been developing rapidly during the latest decade. However, all current technologies of driving automation still require human drivers’ monitoring and intervention. This meansExpand
  • 4
  • 1
  • PDF
Pancreatoduodenectomy for locally advanced or recurrent colon cancer: Report of two cases
A 66-year-old man, who had ascending colon cancer which invaded the duodenum, pancreas, and superior mesenteric vein, underwent a curative resection including an extended right hemicolectomy,Expand
  • 26
Effects of the neuropeptide APGW-amide and related compounds on molluscan muscles--GW-amide shows potent modulatory effects.
1. Effects of the molluscan neuropeptide APGW-amide and related compounds (the crustacean hormone RPCH, FAPGW-amide, PGW-amide, GW-amide and W-amide) were examined in several kinds of molluscanExpand
  • 19
A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer
BackgroundSorafenib inhibits several receptor tyrosine kinases involved in tumor progression and angiogenesis. S-1, an oral fluorouracil antitumor drug, plus cisplatin (CDDP) is the standard regimenExpand
  • 14
  • PDF
Evaluation of interethnic differences in repinotan pharmacokinetics by using population approach.
Repinotan is a selective full serotonin receptor agonist at the 5-HT1A subtype which has been studied in phase I and II studies involving over 500 healthy subjects and patients. Repinotan isExpand
  • 7
  • PDF